US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.441
  • +0.001+0.11%
Trading Nov 21 14:28 ET
18.30MMarket Cap-458P/E (TTM)

Cognition Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
44.03%10.17M
50.59%7.37M
65.68%9.19M
21.49%25.92M
58.28%8.42M
5.74%7.06M
-16.06%4.89M
58.08%5.55M
91.32%21.33M
-21.04%5.32M
Selling and administrative expenses
-0.16%3.07M
-6.60%3.1M
0.17%3.55M
2.28%13.53M
25.49%3.59M
-29.40%3.08M
6.58%3.32M
22.38%3.54M
31.93%13.23M
-54.13%2.86M
-General and administrative expense
-0.16%3.07M
-6.60%3.1M
0.17%3.55M
2.28%13.53M
25.49%3.59M
-29.40%3.08M
6.58%3.32M
22.38%3.54M
31.93%13.23M
-54.13%2.86M
Research and development costs
-2.37%11.39M
36.25%11.58M
94.35%10.55M
22.66%37.2M
80.12%11.6M
41.13%11.67M
-6.61%8.5M
-16.69%5.43M
63.28%30.32M
15.56%6.44M
Other operating expenses
44.13%-4.29M
-5.57%-7.31M
-43.37%-4.91M
-11.65%-24.81M
-70.06%-6.77M
-29.21%-7.68M
-8.46%-6.93M
41.97%-3.43M
-27.34%-22.22M
21.51%-3.98M
Operating profit
-44.03%-10.17M
-50.59%-7.37M
-65.68%-9.19M
-21.49%-25.92M
-58.28%-8.42M
-5.74%-7.06M
16.06%-4.89M
-58.08%-5.55M
-91.32%-21.33M
21.04%-5.32M
Net non-operating interest income expense
-50.00%-3K
-16.67%-7K
0.00%-10K
3.57%-27K
10.00%-9K
0.00%-2K
14.29%-6K
-11.11%-10K
96.86%-28K
-1,100.00%-10K
Non-operating interest expense
50.00%3K
16.67%7K
0.00%10K
-3.57%27K
-10.00%9K
0.00%2K
-14.29%6K
11.11%10K
-96.86%28K
1,100.00%10K
Other net income (expense)
-24.84%236K
93.60%333K
107.97%49K
551.43%158K
95.24%287K
470.91%314K
509.52%172K
-215.38%-615K
-110.67%-35K
124.34%147K
Special income (charges)
--0
--0
---195K
----
----
--0
--0
--0
----
----
-Gain on sale of business
--0
--0
---195K
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-24.84%236K
93.60%333K
139.67%244K
551.43%158K
95.24%287K
470.91%314K
509.52%172K
-215.38%-615K
98.49%-35K
124.34%147K
Income before tax
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
-20.52%-25.79M
-57.10%-8.14M
-1.87%-6.75M
19.58%-4.73M
-66.23%-6.17M
-82.63%-21.4M
29.39%-5.18M
Income tax
Net income
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
-20.52%-25.79M
-57.10%-8.14M
-1.87%-6.75M
17.84%-4.73M
-60.81%-6.17M
-82.63%-21.4M
29.39%-5.18M
Net income continuous Operations
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
-20.52%-25.79M
-57.10%-8.14M
-1.87%-6.75M
17.84%-4.73M
-60.81%-6.17M
-82.63%-21.4M
29.39%-5.18M
Minority interest income
Net income attributable to the parent company
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
-20.52%-25.79M
-57.10%-8.14M
-1.87%-6.75M
17.84%-4.73M
-60.81%-6.17M
-82.63%-21.4M
29.39%-5.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
-20.52%-25.79M
-57.10%-8.14M
-1.87%-6.75M
17.84%-4.73M
-60.81%-6.17M
-31.69%-21.4M
31.32%-5.18M
Basic earnings per share
-13.64%-0.25
-12.50%-0.18
-28.57%-0.27
5.49%-0.86
-35.00%-0.27
24.14%-0.22
36.00%-0.16
-23.53%-0.21
70.93%-0.91
41.07%-0.2
Diluted earnings per share
-13.64%-0.25
-12.50%-0.18
-28.57%-0.27
5.49%-0.86
-35.00%-0.27
24.14%-0.22
36.00%-0.16
-23.53%-0.21
70.93%-0.91
41.07%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 44.03%10.17M50.59%7.37M65.68%9.19M21.49%25.92M58.28%8.42M5.74%7.06M-16.06%4.89M58.08%5.55M91.32%21.33M-21.04%5.32M
Selling and administrative expenses -0.16%3.07M-6.60%3.1M0.17%3.55M2.28%13.53M25.49%3.59M-29.40%3.08M6.58%3.32M22.38%3.54M31.93%13.23M-54.13%2.86M
-General and administrative expense -0.16%3.07M-6.60%3.1M0.17%3.55M2.28%13.53M25.49%3.59M-29.40%3.08M6.58%3.32M22.38%3.54M31.93%13.23M-54.13%2.86M
Research and development costs -2.37%11.39M36.25%11.58M94.35%10.55M22.66%37.2M80.12%11.6M41.13%11.67M-6.61%8.5M-16.69%5.43M63.28%30.32M15.56%6.44M
Other operating expenses 44.13%-4.29M-5.57%-7.31M-43.37%-4.91M-11.65%-24.81M-70.06%-6.77M-29.21%-7.68M-8.46%-6.93M41.97%-3.43M-27.34%-22.22M21.51%-3.98M
Operating profit -44.03%-10.17M-50.59%-7.37M-65.68%-9.19M-21.49%-25.92M-58.28%-8.42M-5.74%-7.06M16.06%-4.89M-58.08%-5.55M-91.32%-21.33M21.04%-5.32M
Net non-operating interest income expense -50.00%-3K-16.67%-7K0.00%-10K3.57%-27K10.00%-9K0.00%-2K14.29%-6K-11.11%-10K96.86%-28K-1,100.00%-10K
Non-operating interest expense 50.00%3K16.67%7K0.00%10K-3.57%27K-10.00%9K0.00%2K-14.29%6K11.11%10K-96.86%28K1,100.00%10K
Other net income (expense) -24.84%236K93.60%333K107.97%49K551.43%158K95.24%287K470.91%314K509.52%172K-215.38%-615K-110.67%-35K124.34%147K
Special income (charges) --0--0---195K----------0--0--0--------
-Gain on sale of business --0--0---195K----------0--0--0--------
Other non- operating income (expenses) -24.84%236K93.60%333K139.67%244K551.43%158K95.24%287K470.91%314K509.52%172K-215.38%-615K98.49%-35K124.34%147K
Income before tax -47.24%-9.94M-48.98%-7.04M-48.27%-9.15M-20.52%-25.79M-57.10%-8.14M-1.87%-6.75M19.58%-4.73M-66.23%-6.17M-82.63%-21.4M29.39%-5.18M
Income tax
Net income -47.24%-9.94M-48.98%-7.04M-48.27%-9.15M-20.52%-25.79M-57.10%-8.14M-1.87%-6.75M17.84%-4.73M-60.81%-6.17M-82.63%-21.4M29.39%-5.18M
Net income continuous Operations -47.24%-9.94M-48.98%-7.04M-48.27%-9.15M-20.52%-25.79M-57.10%-8.14M-1.87%-6.75M17.84%-4.73M-60.81%-6.17M-82.63%-21.4M29.39%-5.18M
Minority interest income
Net income attributable to the parent company -47.24%-9.94M-48.98%-7.04M-48.27%-9.15M-20.52%-25.79M-57.10%-8.14M-1.87%-6.75M17.84%-4.73M-60.81%-6.17M-82.63%-21.4M29.39%-5.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -47.24%-9.94M-48.98%-7.04M-48.27%-9.15M-20.52%-25.79M-57.10%-8.14M-1.87%-6.75M17.84%-4.73M-60.81%-6.17M-31.69%-21.4M31.32%-5.18M
Basic earnings per share -13.64%-0.25-12.50%-0.18-28.57%-0.275.49%-0.86-35.00%-0.2724.14%-0.2236.00%-0.16-23.53%-0.2170.93%-0.9141.07%-0.2
Diluted earnings per share -13.64%-0.25-12.50%-0.18-28.57%-0.275.49%-0.86-35.00%-0.2724.14%-0.2236.00%-0.16-23.53%-0.2170.93%-0.9141.07%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data